Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
Clinical trial NCT01397162 · TERMINATED
Trial details
- NCT number
- NCT01397162
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-21
- Primary completion
- 2011-12-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.